Denosumab (anti-RANK ligand)

目录号：A2020         批次号: A202001

打印

Denosumab (anti-RANK ligand) (AMG-162) 是是一种全人源单克隆抗体，可选择性抑制灵长类动物 RANKL。Denosumab 可抑制 human RANKL (143–317) 刺激源自鼠 RAW 264.7 细胞的破骨细胞形成的能力，IC50 值为 1.64 nM。

抗体信息

CAS号 615258-40-7
配制 PBS Buffer, pH 7.4
推荐同型对照 human IgG1
来源 HEK293
储存条件
(自收到货起)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
除菌 0.2 μM filtered
纯度 99.34%
蛋白浓度 5 mg/ml
内毒素 <1 EU/mg

Denosumab (anti-RANK ligand)在文献中得到引用

Protocol for constructing in vivo and in vitro models integrating clinical and proteomic subtypes of chordoma [ STAR Protoc, 2025, 6(2):103719] PubMed: 40156836
Clinical-proteomic classification and precision treatment strategy of chordoma [ Cell Rep Med, 2024, 5(10):101757] PubMed: 39368483
TNFSF11/TNFRSF11A Axis Amplifies HDM-Induced Airway Remodeling by Strengthening TGFβ1/STAT3 Action [ Allergy Asthma Immunol Res, 2024, 16(4):399-421] PubMed: 39155739
Rapamycin Inhibits Osteoclastogenesis and Prevents LPS-Induced Alveolar Bone Loss by Oxidative Stress Suppression [ ACS Omega, 2023, 8(23):20739-20754] PubMed: 37323396

禁止用于人体及治疗！